
TY  - JOUR
TI  - VASCULITIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_31.x
DO  - doi:10.1111/j.1479-8077.2006.00199_31.x
SP  - A274
EP  - A278
PY  - 2006
ER  - 

TY  - JOUR
AU  - Wang, Yi
AU  - Subbiahdoss, Guruprakash
AU  - Swartjes, Jan
AU  - van der Mei, Henny C.
AU  - Busscher, Henk J.
AU  - Libera, Matthew
TI  - Length-Scale Mediated Differential Adhesion of Mammalian Cells and Microbes
JO  - Advanced Functional Materials
JA  - Adv. Funct. Mater.
VL  - 21
IS  - 20
SN  - 1616-301X
UR  - https://doi.org/10.1002/adfm.201100659
DO  - doi:10.1002/adfm.201100659
SP  - 3916
EP  - 3923
KW  - biomaterials
KW  - infection
KW  - bacteria
KW  - cell adhesion
KW  - hydrogel
KW  - patterning
PY  - 2011
AB  - Abstract Surfaces of implantable biomedical devices are increasingly engineered to promote their interactions with tissue. However, surfaces that stimulate desirable mammalian cell adhesion, spreading, and proliferation also enable microbial colonization. The biomaterials-associated infection that can result is now a critical clinical problem. We have identified an important mechanism to create a surface that can simultaneously promote healing while reducing the probability of infection. Surfaces are created with submicrometer-sized, non-adhesive microgels patterned on an otherwise cell-adhesive surface. Quantitative force measurements between a staphylococcus and a patterned surface show that the adhesion strength decreases significantly at inter-gel spacings comparable to bacterial dimensions. Time-resolved flow-chamber measurements show that the microbial deposition rate dramatically decreases at these same spacings. Importantly, the adhesion and spreading of osteoblast-like cells is preserved despite the sub-cellular non-adhesive surface features. Since such length-scale-mediated differential interactions do not rely on antibiotics, this mechanism can be particularly significant in mitigating biomaterials-associated infection by antibiotic-resistant bacteria such as MRSA.
ER  - 

TY  - JOUR
AU  - Konstantinides, Frank N.
TI  - Nitrogen Balance Studies in Clinical Nutrition
JO  - Nutrition in Clinical Practice
JA  - Nutrition in Clinical Practice
VL  - 7
IS  - 5
SN  - 0884-5336
UR  - https://doi.org/10.1177/0115426592007005231
DO  - doi:10.1177/0115426592007005231
SP  - 231
EP  - 238
PY  - 1992
AB  - Nutrition support is recognized as an important cofactor in altering morbidity and mortality of hospitalized patients. Paramount in delivering proper nutrition support is the accurate determination of baseline metabolic and nutritional status, thus influencing necessary protein requirements. After nutritional intervention, routine laboratory monitoring is used to measure the efficacy and to reassess metabolic stress level. Accurate determination of nitrogen excretion (and nitrogen balance) remains the standard in prescribing and monitoring the protein and nutritional treatment regimen. This article examines nitrogen excretion determinations in the clinical setting, including proper collection techniques, laboratory measurements, and analyses and their effect upon nitrogen balance studies.
ER  - 

TY  - JOUR
TI  - Workshops
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 46
IS  - S1
SN  - 0014-2972
UR  - https://doi.org/10.1111/eci.12604
DO  - doi:10.1111/eci.12604
SP  - 6
EP  - 119
PY  - 2016
ER  - 

TY  - JOUR
TI  - Monday, 25 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_1.x
DO  - doi:10.1111/j.1538-7836.2011.04380_1.x
SP  - 1
EP  - 250
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts Poster
JO  - American Journal of Transplantation
VL  - 9
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2009.02659.x
DO  - doi:10.1111/j.1600-6143.2009.02659.x
SP  - 384
EP  - 729
PY  - 2009
ER  - 

TY  - JOUR
AU  - Roeser, Michelle M.
AU  - Friedman, Oren
AU  - Moore, Eric J.
TI  - Current Practices in Microtia Repair
JO  - The Laryngoscope
JA  - The Laryngoscope
VL  - 119
IS  - S1
SN  - 0023-852X
UR  - https://doi.org/10.1002/lary.20426
DO  - doi:10.1002/lary.20426
SP  - S125
EP  - S125
PY  - 2009
ER  - 

TY  - JOUR
TI  - MODERATED POSTER SESSION ABSTRACTS
JO  - The Journal of Sexual Medicine
VL  - 3
IS  - s3
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2006.00188_3.x
DO  - doi:10.1111/j.1743-6109.2006.00188_3.x
SP  - 199
EP  - 223
PY  - 2006
ER  - 

TY  - JOUR
TI  - Posters
JO  - Clinical Microbiology and Infection
VL  - 16
IS  - s2
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2010.03239.x
DO  - doi:10.1111/j.1469-0691.2010.03239.x
SP  - S133
EP  - S634
PY  - 2010
ER  - 

TY  - JOUR
AU  - Lee, Angela C.
AU  - Reduque, Leila L.
AU  - Luban, Naomi L.C.
AU  - Ness, Paul M.
AU  - Anton, Blair
AU  - Heitmiller, Eugenie S.
TI  - Transfusion-associated hyperkalemic cardiac arrest in pediatric patients receiving massive transfusion
JO  - Transfusion
JA  - Transfusion
VL  - 54
IS  - 1
SN  - 0041-1132
UR  - https://doi.org/10.1111/trf.12192
DO  - doi:10.1111/trf.12192
SP  - 244
EP  - 254
PY  - 2014
AB  - Background Hyperkalemic cardiac arrest is a potential complication of massive transfusion in children. Our objective was to identify risk factors and potential preventive measures by reviewing the literature on transfusion-associated hyperkalemic cardiac arrest (TAHCA) in the pediatric population. Study Design and Methods Literature searches were performed in MEDLINE and the Cochrane Database of Systematic Reviews. Results We identified nine case reports of pediatric patients who had experienced cardiac arrest during massive transfusion. Serum potassium concentration was reported in eight of those reports; the mean was 9.2?±?1.8?mmol/L. Risk factors for TAHCA noted in the case reports included infancy (n?=?6); age of red blood cells (RBCs; n?=?5); site of transfusion (n?=?5); and the presence of comorbidities such as hyperkalemia, hypocalcemia, acidemia, and hypotension (n?=?9). We also identified 13 clinical studies that examined potassium levels associated with transfusion. Of those 13, five studied routine transfusion, two were registries, and six examined massive transfusion. Conclusions Key points identified from this literature search are as follows: 1) Case reports are skewed toward infants and neonates in particular and 2) the rate of blood transfusion, more so than total volume, cardiac output, and the site of infusion, are key factors in the development of TAHCA. Measures to reduce the risk of TAHCA in young children include anticipating and replacing blood loss before significant hemodynamic compromise occurs, using larger-bore (>23-gauge) peripheral intravenous catheters rather than central venous access, checking and correcting electrolyte abnormalities frequently, and using fresher RBCs for massive transfusion.
ER  - 

TY  - JOUR
TI  - American Society for Laser Medicine and Surgery thirteenth annual meeting New Orleans, Louisiana abstracts
JO  - Lasers in Surgery and Medicine
JA  - Lasers Surg. Med.
VL  - 13
IS  - S5
SN  - 0196-8092
UR  - https://doi.org/10.1002/lsm.1900130702
DO  - doi:10.1002/lsm.1900130702
SP  - 1
EP  - 77
PY  - 1993
ER  - 

TY  - JOUR
AU  - Liu, Chih-Wei
AU  - Atkinson, Mark A.
AU  - Zhang, Qibin
TI  - Type 1 diabetes cadaveric human pancreata exhibit a unique exocrine tissue proteomic profile
JO  - PROTEOMICS
JA  - Proteomics
VL  - 16
IS  - 9
SN  - 1615-9853
UR  - https://doi.org/10.1002/pmic.201500333
DO  - doi:10.1002/pmic.201500333
SP  - 1432
EP  - 1446
KW  - Biomedicine
KW  - Isobaric labeling
KW  - nPOD
KW  - Pancreas proteome
KW  - TMT10
KW  - Type 1 diabetes
PY  - 2016
AB  - Type 1 diabetes (T1D) is an autoimmune disorder resulting from a self-destruction of pancreatic islet beta cells. The complete proteome of the human pancreas, where both the dysfunctional beta cells and their proximal environment co-exist, remains unknown. Here, we used TMT10-based isobaric labeling and multidimensional LC-MS/MS to quantitatively profile the differences between pancreatic head region tissues from T1D (N = 5) and healthy subjects (N = 5). Among the 5357 (1% false discovery rate) confidently identified proteins, 145 showed statistically significant dysregulation between T1D and healthy subjects. The differentially expressed pancreatic proteome supports the growing notion of a potential role for exocrine pancreas involvement in T1D. This study also demonstrates the utility for this approach to analyze dysregulated proteins as a means to investigate islet biology, pancreatic pathology and T1D pathogenesis.
ER  - 

TY  - JOUR
TI  - GENOMICS, GENETIC BASIS OF DISEASE AND HLA/T CELL RECOGNITION
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_11.x
DO  - doi:10.1111/j.1479-8077.2006.00199_11.x
SP  - A66
EP  - A68
PY  - 2006
ER  - 

TY  - JOUR
TI  - INFECTION-RELATED RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_14.x
DO  - doi:10.1111/j.1479-8077.2006.00199_14.x
SP  - A80
EP  - A83
PY  - 2006
ER  - 

TY  - JOUR
TI  - MISCELLANEOUS RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_16.x
DO  - doi:10.1111/j.1479-8077.2006.00199_16.x
SP  - A90
EP  - A99
PY  - 2006
ER  - 

TY  - JOUR
TI  - OSTEOPOROSIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_20.x
DO  - doi:10.1111/j.1479-8077.2006.00199_20.x
SP  - A125
EP  - A142
PY  - 2006
ER  - 

TY  - JOUR
TI  - SPONDYLOARTHROPATHIES INCLUDING PSORIATIC ARTHRITIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_28.x
DO  - doi:10.1111/j.1479-8077.2006.00199_28.x
SP  - A234
EP  - A247
PY  - 2006
ER  - 

TY  - JOUR
TI  - BACK PAIN
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_3.x
DO  - doi:10.1111/j.1479-8077.2006.00199_3.x
SP  - A26
EP  - A31
PY  - 2006
ER  - 

TY  - JOUR
TI  - BONE DISEASES OTHER THAN OSTEOPOROSIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_4.x
DO  - doi:10.1111/j.1479-8077.2006.00199_4.x
SP  - A31
EP  - A33
PY  - 2006
ER  - 

TY  - JOUR
TI  - ORTHOPAEDIC SURGERY AND SPORTS MEDICINE
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_18.x
DO  - doi:10.1111/j.1479-8077.2006.00199_18.x
SP  - A101
EP  - A108
PY  - 2006
ER  - 
